ECALLANTIDE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 01:06:10 UTC 2023` Edited by `admin` on `Sat Dec 16 01:06:10 UTC 2023`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	5Q6TZN2HNM
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ECALLANTIDE

Official Name

English

ECALLANTIDE [PURPLE BOOK CDER]

Common Name

English

PROTEIN (SYNTHETIC HUMAN PLASMA KALLIKREIN-INHIBITING)

Common Name

English

ECALLANTIDE [VANDF]

Common Name

English

ECALLANTIDE [MART.]

Common Name

English

ECALLANTIDE [MI]

Common Name

English

ECALLANTIDE [USAN]

Common Name

English

Ecallantide [WHO-DD]

Common Name

English

DX-88

Code

English

ecallantide [INN]

Common Name

English

(GLU(SUP 20),ALA(SUP 21),ARG(SUP 36),ALA(SUP 38),HIS(SUP 39),PRO(SUP 40),TRP(SUP 42))TISSUE FACTOR PATHWAY INHIBITOR (HUMAN)-(20 79)-PEPTIDE (MODIFIED ON REACTIVE BOND REGION KUNITZ INHIBITOR 1 DOMAIN CONTAINING FRAGMENT)

Common Name

English

ECALLANTIDE [JAN]

Common Name

English

ESCALLANTIDE

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

160802

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

WHO-VATC

QB06AC03

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

WHO-ATC

B06AC03

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

NCI_THESAURUS

C783

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

NDF-RT

N0000192750

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

Code System Code Type Description

DAILYMED

5Q6TZN2HNM

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

ChEMBL

CHEMBL1201837

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

DRUG CENTRAL

4846

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

NCI_THESAURUS

C65505

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

EVMPD

SUB31283

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

USAN

PP-40

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

DRUG BANK

DB05311

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

HSDB

8225

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

INN

8476

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

CAS

460738-38-9

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

IUPHAR

6955

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

MESH

C511194

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

MERCK INDEX

m4806

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

Merck Index

WIKIPEDIA

ECALLANTIDE

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

RXCUI

658708

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

RxNorm

FDA UNII

5Q6TZN2HNM

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

EPA CompTox

DTXSID90196709

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

PUBCHEM

118984459

Created by admin on Sat Dec 16 01:06:10 UTC 2023 , Edited by admin on Sat Dec 16 01:06:10 UTC 2023

PRIMARY

Related Record Type Details


					X4L6L7841X

PLASMA KALLIKREIN

TARGET -> INHIBITOR

Interaction Type:

BINDING

Qualification:

Ki

Amount:

Related Record Type Details


					5Q6TZN2HNM

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
Volume of Distribution	PHARMACOKINETIC

MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Biological Half-life	PHARMACOKINETIC